HeartSciences Inc.
HSCS
$3.75
$0.3710.95%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Revenue | 4.40K | -- | -- | -- | 0.00 |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 4.40K | -- | -- | -- | 0.00 |
Cost of Revenue | 1.90K | -- | -- | -- | 0.00 |
Gross Profit | 2.50K | -- | -- | -- | 0.00 |
SG&A Expenses | 993.80K | 1.34M | 786.10K | 850.70K | 833.70K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.92M | 2.37M | 1.99M | 2.08M | 1.88M |
Operating Income | -1.92M | -2.37M | -1.99M | -2.08M | -1.88M |
Income Before Tax | -2.09M | -2.54M | -2.08M | -2.05M | -1.85M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -2.09M | -2.54M | -2.08M | -2.05M | -1.85M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -2.09M | -2.54M | -2.08M | -2.05M | -1.85M |
EBIT | -1.92M | -2.37M | -1.99M | -2.08M | -1.88M |
EBITDA | -1.91M | -2.37M | -1.97M | -2.06M | -1.87M |
EPS Basic | -1.96 | -2.57 | -2.27 | -2.64 | -2.83 |
Normalized Basic EPS | -1.22 | -1.61 | -1.42 | -1.65 | -1.77 |
EPS Diluted | -1.96 | -2.57 | -2.27 | -2.64 | -2.83 |
Normalized Diluted EPS | -1.22 | -1.61 | -1.42 | -1.65 | -1.77 |
Average Basic Shares Outstanding | 1.07M | 986.10K | 917.40K | 777.70K | 652.60K |
Average Diluted Shares Outstanding | 1.07M | 986.10K | 917.40K | 777.70K | 652.60K |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |